...
首页> 外文期刊>Journal of Medicinal Chemistry >Design, synthesis, crystal structures, and antimicrobial activity of sulfonamide boronic acids as β-lactamase inhibitors
【24h】

Design, synthesis, crystal structures, and antimicrobial activity of sulfonamide boronic acids as β-lactamase inhibitors

机译:磺酰胺硼酸作为β-内酰胺酶抑制剂的设计,合成,晶体结构和抗菌活性

获取原文
获取原文并翻译 | 示例

摘要

We investigated a series of sulfonamide boronic acids that resulted from the merging of two unrelated AmpC β-lactamase inhibitor series. The new boronic acids differed in the replacement of the canonical carboxamide, found in all penicillin and cephalosporin antibiotics, with a sulfonamide. Surprisingly, these sulfonamides had a highly distinct structure-activity relationship from the previously explored carboxamides, high ligand efficiencies (up to 0.91), and K_i values down to 25 nM and up to 23 times better for smaller analogues. Conversely, K_i values were 10-20 times worse for larger molecules than in the carboxamide congener series. X-ray crystal structures (1.6-1.8 ?) of AmpC with three of the new sulfonamides suggest that this altered structure-activity relationship results from the different geometry and polarity of the sulfonamide versus the carboxamide. The most potent inhibitor reversed β-lactamase-mediated resistance to third generation cephalosporins, lowering their minimum inhibitory concentrations up to 32-fold in cell culture.
机译:我们研究了由两个不相关的AmpCβ-内酰胺酶抑制剂系列合并产生的一系列磺酰胺硼酸。新的硼酸的区别在于,在所有青霉素和头孢菌素抗生素中都发现的典型羧酰胺被磺酰胺替代。令人惊讶地,这些磺酰胺具有与先前探索的羧酰胺高度不同的结构-活性关系,具有高的配体效率(高达0.91),K_i值低至25 nM,对于较小的类似物则高达23倍。相反,较大分子的K_i值比羧酰胺同类物系列差10-20倍。具有三种新磺酰胺的AmpC的X射线晶体结构(1.6-1.8?)表明,这种改变的结构活性关系是由于磺酰胺与羧酰胺的几何形状和极性不同而引起的。最有效的抑制剂逆转了β-内酰胺酶介导的对第三代头孢菌素的耐药性,从而将其最小抑菌浓度降低到细胞培养物中的32倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号